The Challenges of the New EU Pharmaceutical Legislation (Paperback)
  • The Challenges of the New EU Pharmaceutical Legislation (Paperback)
zoom

The Challenges of the New EU Pharmaceutical Legislation (Paperback)

(editor), (editor)
£60.00
Paperback 148 Pages / Published: 01/01/2005
  • Not available

This product is currently unavailable

This product is currently unavailable.

  • This item has been added to your basket
In the domain of public policy on pharmaceuticals, protecting public health requires a dual strategy: robust regulation on the one hand and stimulation of competitiveness and innovation on the other. Regulation must be robust to ensure that only medicines meetings exacting standards of safety, quality and efficacy are authorised for human and animal use. At the same time competitiveness and innovation must be stimulated. Without innovation in pharmaceuticals, the incurable diseases of today will remain incurable. Competitiveness drives innovation and innovation saves lives. This dual strategy is also crucial in driving forward the Lisbon agenda. Increased competitiveness of the pharmaceutical sector will not only better protect public health, but will also create high quality jobs and create growth. In this context the implementation of the G10 recommendations, particularly regarding the pricing and reimbursement of medicines by Member States, remains a considerable challenge. In order to make potentially life-saving pharmaceuticals available as soon as possible to patients and to enable industry to quickly recoup its investments and to reinvest into future R&D, still existing delays in some Member States between marketing authorization and the selling of the medicine have to be minimized. The proposed paediatric regulation, currently under discussion in Council and Parliament, is another example where a better protection of (children's) health goes together with a stimulation of competitiveness and innovation in the European pharmaceutical industry. This publication focuses on the recent review of the EU pharmaceutical legislation. The revised legislation is a key part of the above-mentioned dual strategy.

Publisher: IOS Press
ISBN: 9781586035211
Number of pages: 148

You may also be interested in...

The Secret Barrister
Added to basket
£9.99   £7.99
Paperback
Poppy The Street Dog
Added to basket
Work Like a Woman
Added to basket
£9.99
Paperback
East West Street
Added to basket
£9.99   £8.49
Paperback
Heroic Animals
Added to basket
£20.00
Hardback
How Animals Saved My Life: Being the Supervet
Added to basket
Fake Law
Added to basket
£20.00   £16.99
Hardback
Court Number One
Added to basket
£10.99   £8.99
Paperback
Corona, False Alarm?
Added to basket
In Your Defence
Added to basket
£9.99
Paperback
The Pembrokeshire Murders
Added to basket
The Ten Types of Human
Added to basket
The Brussels Effect
Added to basket
The Rule of Law
Added to basket
£9.99
Paperback
In Black and White
Added to basket
The Silence
Added to basket
£14.99
Hardback

Please sign in to write a review

Your review has been submitted successfully.